
Uncategorized - September 6, 2017
Predicting the effects of cancer treatment
An international research team has developed a mathematical model that predicts the side effects of a chemotherapy treatment for prostate cancer. Around 10-20 percent of patients have adverse side effects from the standard treatment with the chemotherapy drug docetaxel that forces them to discontinue the treatment. In the Prostate Cancer DREAM 9.5 Challenge, international researcher […]

Uncategorized - May 13, 2015
Scientists Map Multiple Proteins
Danish researchers at the University of Copenhagen have discovered how to map more than one protein at a time, when proteins repair damaged DNA. The discovery could help accelerate the process of developing better and gentler cancer treatments. The research is described in an article in the scientific journal, Science. When DNA is damaged, several […]

Collaboration - April 27, 2015
Juno, AZ Testing Cancer Remedy
Juno Therapeutics and AstraZeneca are joining forces to test their respective cancer treatments, combining new therapies designed to use the body’s immune system to combat tumors. Under the deal, the pair plans to jointly fund a Phase I study combining one of Juno’s CAR-T therapies and pair it with a promising antibody developed by MedImmune, […]

Funding - November 25, 2014
Beactica Receives Grant
Beactica, the Swedish fragment-based drug discovery company, announced that it has been awarded a SEK 3.0 million grant from the Swedish Governmental Agency for Innovation Systems (VINNOVA). The grant will be used to support the development of a new epigenetic drug for treatment of cancer. The goal of Beactica’s project is to develop novel compounds for […]